+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Comprehensive Metabolic Panel Testing Market by Disease, Test Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5336338
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Comprehensive Metabolic Panel Testing Market grew from USD 9.28 billion in 2023 to USD 10.26 billion in 2024. It is expected to continue growing at a CAGR of 10.65%, reaching USD 18.86 billion by 2030.

The Comprehensive Metabolic Panel (CMP) testing market involves diagnostics that measure sugar (glucose) levels, electrolyte and fluid balance, kidney functioning, and liver functioning. With its broad utility in diagnosing conditions like diabetes, liver disease, and kidney dysfunction, the CMP is a critical tool for medical professionals. It is regularly applied in routine health check-ups, emergency room settings, and monitoring chronic diseases. End-users predominantly include hospitals, diagnostic centers, and clinical laboratories. Market growth is significantly driven by the increasing prevalence of lifestyle diseases due to the global shift towards sedentary lifestyles and unhealthy diets. Additionally, advancements in technology such as automation in laboratories and the integration of artificial intelligence in diagnostics represent substantial opportunities for market players. The growing demand for personalized medicine that requires regular monitoring of physiological parameters also boosts the need for CMP testing. However, limitations such as the high cost of advanced diagnostic equipment and a lack of skilled professionals to operate these technologies can impede growth. Stringent regulatory frameworks and reimbursement issues further pose challenges. For market players looking to capitalize on growth opportunities, investing in innovation such as developing cost-effective and rapid point-of-care CMP testing kits can provide a competitive edge. Moreover, partnerships with healthcare institutions for awareness programs might amplify market reach. Focusing on the scalability of AI-based data analytics platforms to predict and manage metabolic abnormalities could enhance diagnostic accuracy and expand market applications. The market is competitively fragmented with key players focusing on strategic mergers and acquisitions to increase their foothold. Overall, the comprehensive metabolic panel testing market offers substantial growth potential, with the introduction of new healthcare policies and increasing healthcare expenditure in developing economies likely to play a pivotal role in future progress.

Understanding Market Dynamics in the Comprehensive Metabolic Panel Testing Market

The Comprehensive Metabolic Panel Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing incidence of chronic diseases
    • Potential need for early diagnosis and treatment among the population
    • Rising elderly population coupled with increase in biopsy processes
  • Market Restraints
    • Probability of false results on testing
  • Market Opportunities
    • Emerging introduction of innovative solutions to improve efficiency and reduce errors
    • Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
  • Market Challenges
    • Changing regulatory system creating ambiguity among manufacturers

Exploring Porter’s Five Forces for the Comprehensive Metabolic Panel Testing Market

Porter’s Five Forces framework further strengthens the insights of the Comprehensive Metabolic Panel Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Comprehensive Metabolic Panel Testing Market

External macro-environmental factors deeply influence the performance of the Comprehensive Metabolic Panel Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Comprehensive Metabolic Panel Testing Market

The Comprehensive Metabolic Panel Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Comprehensive Metabolic Panel Testing Market

The Comprehensive Metabolic Panel Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Comprehensive Metabolic Panel Testing Market

The Comprehensive Metabolic Panel Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Comprehensive Metabolic Panel Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis by Zoetis Inc., Abbott Laboratories, ARUP Laboratories, Baptist Health Medical Group, CENTOGENE N.V., Cleveland HeartLab, Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Private MD Labs, Quest Diagnostics Incorporated, Scion Lab Services, LLC, Siemens Healthcare GmbH, SYNLAB International GmbH, Testing.com by OneCare Media, and Walk-In Lab, LLC.

Market Segmentation & Coverage

This research report categorizes the Comprehensive Metabolic Panel Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Disease
    • Diabetes
    • Kidney Disease
    • Liver Disease
  • Test Type
    • Electrolytes
    • Glucose
    • Kidney Tests
    • Liver Functional Tests
    • Proteins
  • End-User
    • Laboratory
    • PoC
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidence of chronic diseases
5.1.1.2. Potential need for early diagnosis and treatment among the population
5.1.1.3. Rising elderly population coupled with increase in biopsy processes
5.1.2. Restraints
5.1.2.1. Probability of false results on testing
5.1.3. Opportunities
5.1.3.1. Emerging introduction of innovative solutions to improve efficiency and reduce errors
5.1.3.2. Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
5.1.4. Challenges
5.1.4.1. Changing regulatory system creating ambiguity among manufacturers
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Comprehensive Metabolic Panel Testing Market, by Disease
6.1. Introduction
6.2. Diabetes
6.3. Kidney Disease
6.4. Liver Disease
7. Comprehensive Metabolic Panel Testing Market, by Test Type
7.1. Introduction
7.2. Electrolytes
7.3. Glucose
7.4. Kidney Tests
7.5. Liver Functional Tests
7.6. Proteins
8. Comprehensive Metabolic Panel Testing Market, by End-User
8.1. Introduction
8.2. Laboratory
8.3. PoC
9. Americas Comprehensive Metabolic Panel Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Comprehensive Metabolic Panel Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Comprehensive Metabolic Panel Testing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET RESEARCH PROCESS
FIGURE 2. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COMPREHENSIVE METABOLIC PANEL TESTING MARKET DYNAMICS
TABLE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER FUNCTIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 31. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 48. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 51. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 103. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 115. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 118. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Comprehensive Metabolic Panel Testing Market, which are profiled in this report, include:
  • Abaxis by Zoetis Inc.
  • Abbott Laboratories
  • ARUP Laboratories
  • Baptist Health Medical Group
  • CENTOGENE N.V.
  • Cleveland HeartLab, Inc.
  • Laboratory Corporation of America Holdings
  • NeoGenomics Laboratories, Inc.
  • Private MD Labs
  • Quest Diagnostics Incorporated
  • Scion Lab Services, LLC
  • Siemens Healthcare GmbH
  • SYNLAB International GmbH
  • Testing.com by OneCare Media
  • Walk-In Lab, LLC

Methodology

Loading
LOADING...

Table Information